MedTrace Logo

Anti-mullerian Hormone (AMH) After Treatment of Endometriomas With Alcohol Sclerotherapy Versus Surgery: Clinical Trial

NCT03571776 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 158

Last updated 2023-03-02

No results posted yet for this study

Summary

The purpose of this multicenter study is to compare the ovarian reserve after alcohol sclerosis of the endometriomas against conventional surgery (AMH, follicle stimulating hormone (FSH) and antral follicles count) as well as the complications and costs between the 2 procedures.

Conditions

  • Endometrioma
  • Fertility Disorders

Interventions

PROCEDURE

Surgery

Laparoscopic ovarian cystectomy

PROCEDURE

Sclerotherapy

US-aspiration and alcohol sclerosis

Sponsors & Collaborators

  • Hospital Universitari de Bellvitge

    lead OTHER

Principal Investigators

  • Amparo Garcia-Tejedor, MDPhD · Hospital de Bellvitge. IDIBELL

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-05
Primary Completion
2023-01-15
Completion
2023-01-15

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03571776 on ClinicalTrials.gov